Serum-Based Proteomics Reveals Lipid Metabolic and Immunoregulatory Dysregulation in Cervical Artery Dissection With

Yongtao Yang1, Jing Peng2, Suxia Wang3

  • 1Department of Neurology, Chongqing Renji Hospital, University of Chinese Academy of Sciences, Chongqing, China.

Insights

Cervical artery dissection (CAD) is a major cause of stroke. Proteomic analysis identified six upregulated serum proteins, suggesting early immune and lipid metabolism changes in CAD pathophysiology and potential biomarkers for stroke risk.

Area of Science:

  • Proteomics
  • Biochemistry
  • Neurology

Background:

  • Cervical artery dissection (CAD) is a significant cause of stroke in younger populations.
  • The underlying pathophysiological mechanisms of CAD are not well understood.
  • Identifying biomarkers for CAD is crucial for early detection and risk assessment.

Purpose of the Study:

  • To identify differentially expressed proteins in serum from patients with spontaneous cervical artery dissection (CAD) compared to non-CAD ischemic stroke.
  • To investigate the pathophysiological pathways involved in CAD using proteomic analysis.
  • To validate potential protein biomarkers for CAD detection.

Main Methods:

  • Quantitative proteomic analysis using isobaric tagging for relative and absolute quantitation (iTRAQ) on serum samples.
  • Bioinformatic analysis of differentially expressed proteins, including Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway overrepresentation.
  • Enzyme-linked immunosorbent assay (ELISA) validation of six selected differential proteins.

Main Results:

  • Proteomic analysis revealed significant differences in protein expression between CAD and non-CAD ischemic stroke subjects.
  • KEGG pathway analysis indicated involvement of immunoregulation, blood coagulation, and lipid metabolism.
  • Six proteins—apolipoprotein B, apolipoprotein C-I, lipopolysaccharide-binding protein, vascular cell adhesion molecule 1, fibulin-1, and ficolin-2—were significantly upregulated in CAD.

Conclusions:

  • Proteomic analysis suggests early alterations in immunoregulation and lipid metabolism pathways are implicated in CAD pathophysiology.
  • The identified panel of six proteins shows promise as serum-based biomarkers for detecting increased CAD risk in stroke patients.
  • Further research is warranted to confirm the diagnostic and prognostic value of these protein biomarkers.